From January 19, 2023 to March 31, 2023, the company has repurchased 445,711 shares, representing 1.97% for $0.51 million. With this, the company has completed the repurchase of 445,711 shares, representing 1.97% for $0.51 million under the buyback announced on January 19, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.95 USD | +17.66% | -34.03% | -96.50% |
Apr. 19 | Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product | MT |
Apr. 19 | Top Premarket Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-96.50% | 854K | |
+26.47% | 664B | |
+26.00% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.60% | 234B | |
+4.83% | 199B | |
-10.06% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- SBFM Stock
- News Sunshine Biopharma, Inc.
- Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.